PL327137A1 - Pain relieving agent - Google Patents
Pain relieving agentInfo
- Publication number
- PL327137A1 PL327137A1 PL96327137A PL32713796A PL327137A1 PL 327137 A1 PL327137 A1 PL 327137A1 PL 96327137 A PL96327137 A PL 96327137A PL 32713796 A PL32713796 A PL 32713796A PL 327137 A1 PL327137 A1 PL 327137A1
- Authority
- PL
- Poland
- Prior art keywords
- pain relieving
- relieving agent
- agent
- pain
- relieving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US829995P | 1995-12-07 | 1995-12-07 | |
| PCT/US1996/019309 WO1997020561A1 (en) | 1995-12-07 | 1996-12-05 | Composition for treating pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL327137A1 true PL327137A1 (en) | 1998-11-23 |
Family
ID=21730869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96327137A PL327137A1 (en) | 1995-12-07 | 1996-12-05 | Pain relieving agent |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0871445A4 (cs) |
| JP (1) | JP2000501709A (cs) |
| KR (1) | KR19990071976A (cs) |
| CN (1) | CN1208349A (cs) |
| AU (1) | AU705031B2 (cs) |
| CA (1) | CA2238815A1 (cs) |
| CZ (1) | CZ174698A3 (cs) |
| EA (1) | EA199800533A1 (cs) |
| IL (1) | IL124419A0 (cs) |
| NO (1) | NO982562L (cs) |
| NZ (1) | NZ324988A (cs) |
| PL (1) | PL327137A1 (cs) |
| WO (1) | WO1997020561A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1007041A4 (en) * | 1997-04-11 | 2001-03-07 | Lilly Co Eli | COMPOSITION FOR TREATING PAIN |
| ATE248166T1 (de) | 1999-06-04 | 2003-09-15 | Lilly Co Eli | 7-oxo-2-azabicyclo(2.2.1)heptane als selektive muskarin-rezeptor antagonisten |
| US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| JP6371463B2 (ja) | 2014-07-17 | 2018-08-08 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド | 即時放出性乱用抑止性液体充填剤形 |
| WO2016064873A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| US12396988B2 (en) * | 2019-04-04 | 2025-08-26 | Board Of Regents, The University Of Texas System | Methods of using muscarinic antagonists in the treatment of depression |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2998450A (en) * | 1958-05-19 | 1961-08-29 | Warner Lambert Pharmaceutical | Process of preparing nu-acetyl-p-amino phenol |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| US5260293A (en) * | 1988-01-30 | 1993-11-09 | Merck Sharp & Dohme Limited | Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia |
| IL89351A0 (en) * | 1988-03-14 | 1989-09-10 | Lundbeck & Co As H | 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them |
| US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| CA2185805A1 (en) * | 1994-03-18 | 1995-09-28 | Georg Frank | Low dosage ketoprofen |
-
1996
- 1996-12-05 KR KR1019980704267A patent/KR19990071976A/ko not_active Withdrawn
- 1996-12-05 PL PL96327137A patent/PL327137A1/xx unknown
- 1996-12-05 CZ CZ981746A patent/CZ174698A3/cs unknown
- 1996-12-05 IL IL12441996A patent/IL124419A0/xx unknown
- 1996-12-05 CA CA002238815A patent/CA2238815A1/en not_active Abandoned
- 1996-12-05 AU AU12791/97A patent/AU705031B2/en not_active Ceased
- 1996-12-05 WO PCT/US1996/019309 patent/WO1997020561A1/en not_active Ceased
- 1996-12-05 JP JP9521397A patent/JP2000501709A/ja active Pending
- 1996-12-05 CN CN96199837A patent/CN1208349A/zh active Pending
- 1996-12-05 EP EP96943584A patent/EP0871445A4/en not_active Withdrawn
- 1996-12-05 EA EA199800533A patent/EA199800533A1/ru unknown
- 1996-12-05 NZ NZ324988A patent/NZ324988A/xx unknown
-
1998
- 1998-06-04 NO NO982562A patent/NO982562L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0871445A4 (en) | 2001-01-10 |
| KR19990071976A (ko) | 1999-09-27 |
| CZ174698A3 (cs) | 1998-10-14 |
| NO982562L (no) | 1998-07-10 |
| JP2000501709A (ja) | 2000-02-15 |
| NZ324988A (en) | 1999-08-30 |
| WO1997020561A1 (en) | 1997-06-12 |
| AU705031B2 (en) | 1999-05-13 |
| CA2238815A1 (en) | 1997-06-12 |
| EA199800533A1 (ru) | 1999-02-25 |
| NO982562D0 (no) | 1998-06-04 |
| EP0871445A1 (en) | 1998-10-21 |
| IL124419A0 (en) | 1998-12-06 |
| CN1208349A (zh) | 1999-02-17 |
| AU1279197A (en) | 1997-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2298440B (en) | Well treatment | |
| GB9505491D0 (en) | Therapeutic agents | |
| GB9513121D0 (en) | Therapeutic agents | |
| GB9513118D0 (en) | Therapeutic agents | |
| GB9523244D0 (en) | Therapeutic agents | |
| GB9513117D0 (en) | Therapeutic agents | |
| GB9505492D0 (en) | Therapeutic agents | |
| GB9507291D0 (en) | Therapeutic agents | |
| GB9519033D0 (en) | Treatment | |
| GB9519563D0 (en) | Therapeutic agents | |
| GB9507348D0 (en) | Therapeutic agents | |
| GB9500580D0 (en) | Therapeutic agents | |
| GB9501865D0 (en) | Therapeutic agents | |
| GB9523250D0 (en) | Therapeutic agents | |
| PL327137A1 (en) | Pain relieving agent | |
| GB9513467D0 (en) | Therapeutic agents | |
| GB9523243D0 (en) | Therapeutic agents | |
| GB9521781D0 (en) | Therapeutic agents | |
| GB9522495D0 (en) | Therapeutic agents | |
| GB9523065D0 (en) | Therapeutic agents | |
| GB9510223D0 (en) | Therapeutic agent | |
| GB9520731D0 (en) | Therapeutic agents | |
| GB9523460D0 (en) | Therapeutic agents | |
| GB9523064D0 (en) | Therapeutic agents | |
| GB9519558D0 (en) | Therapeutic agents |